Seoul National University Pituitary Disease Cohort Study
NCT ID: NCT03474601
Last Updated: 2020-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1600 participants
OBSERVATIONAL
2015-03-15
2025-02-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Characteristics and Analysis of Pituitary Complex and Rare Diseases
NCT06435195
The Treatment and Natural History of Acromegaly
NCT00001981
The Observational Study of Growth Hormone-secreting Pituitary Tumors
NCT01368133
Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma
NCT03439709
Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease
NCT04339751
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Adults, male or female aged 18 years or older
2. Have been diagnosed with pituitary diseases
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acromegaly
Patients diagnosed with acromegaly
Dynamic hormone study and Magnetic resonance imaging
1. Medical history
2. Imaging examination including brain magnetic resonance imaging
3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Cushing's disease
Patients diagnosed with Cushing's disease
Dynamic hormone study and Magnetic resonance imaging
1. Medical history
2. Imaging examination including brain magnetic resonance imaging
3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Hyperprolactinemia/prolactinomas
Patients diagnosed with hyperprolactinemia/prolactinoma
Dynamic hormone study and Magnetic resonance imaging
1. Medical history
2. Imaging examination including brain magnetic resonance imaging
3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Pituitary stalk lesions
Patients diagnosed with pituitary stalk lesions
Dynamic hormone study and Magnetic resonance imaging
1. Medical history
2. Imaging examination including brain magnetic resonance imaging
3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Nonfunctioning pituitary adenomas
Patients diagnosed with nonfunctioning pituitary adenomas
Dynamic hormone study and Magnetic resonance imaging
1. Medical history
2. Imaging examination including brain magnetic resonance imaging
3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Central diabetes insipidus
Patients diagnosed with central diabetes insipidus
Dynamic hormone study and Magnetic resonance imaging
1. Medical history
2. Imaging examination including brain magnetic resonance imaging
3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Craniopharyngioma
Patients diagnosed with craniopharyngiomas
Dynamic hormone study and Magnetic resonance imaging
1. Medical history
2. Imaging examination including brain magnetic resonance imaging
3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Others
Patients diagnosed with other suprasellar/parasellar lesions
Dynamic hormone study and Magnetic resonance imaging
1. Medical history
2. Imaging examination including brain magnetic resonance imaging
3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dynamic hormone study and Magnetic resonance imaging
1. Medical history
2. Imaging examination including brain magnetic resonance imaging
3. Blood (Basal hormone study and follow-up study) and pituitary tumor tissue
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Adults, male or female aged 18 years or older
2. diagnosed with pituitary diseases such as acromegaly, Cushing's disease, hyperprolactinemia, nonfunctioning pituitary adenoma, pituitary stalk lesions, central diabetes insipidus, and craniopharyngiomas
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jung Hee Kim
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jung Hee Kim, M.D
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1503-040-654
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.